MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « MeshFr.i » - entrée « Modèles logistiques »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Modèles linéaires < Modèles logistiques < Modèles moléculaires  Facettes :

List of bibliographic references indexed by Modèles logistiques

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
001198 (2018) Lianne Kearsley-Fleet [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Diederik De Cock [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Helen E. Foster [Royaume-Uni] ; Taunton R. Southwood [Royaume-Uni] ; Wendy Thomson [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
001205 (2018) Jean-Hugues Salmon ; Jeanne-Marie Perotin ; Jacques Morel [France] ; Moustapha Dramé ; Alain Cantagrel [France] ; Liana Euller Ziegler ; Philippe Ravaud [France] ; Jean Sibilia ; Isabelle Pane [France] ; Xavier Mariette ; Jacques-Eric Gottenberg [France]Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
001399 (2018) Yukimi Otsuka [Japon] ; Chikako Kiyohara [Japon] ; Yusuke Kashiwado [Japon] ; Takuya Sawabe [Japon] ; Shuji Nagano [Japon] ; Yasutaka Kimoto [Japon] ; Masahiro Ayano [Japon] ; Hiroki Mitoma [Japon] ; Mitsuteru Akahoshi [Japon] ; Yojiro Arinobu [Japon] ; Hiroaki Niiro [Japon] ; Koichi Akashi [Japon] ; Takahiko Horiuchi [Japon]Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study.
001815 (2017) Sara Monti [Italie] ; Catherine Klersy [Italie] ; Roberto Gorla [Italie] ; Piercarlo Sarzi-Puttini [Italie] ; Fabiola Atzeni [Italie] ; Raffaele Pellerito [Italie] ; Enrico Fusaro [Italie] ; Giuseppe Paolazzi [Italie] ; Pier Andrea Rocchetta [Italie] ; Ennio Giulio Favalli [Italie] ; Antonio Marchesoni [Italie] ; Roberto Caporali [Italie]Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
001901 (2017) Jessica M. Franklin [États-Unis] ; Sebastian Schneeweiss [États-Unis] ; Daniel H. Solomon [États-Unis]Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.
001B35 (2016) Tadashi Okano [Japon] ; Kentaro Inui [Japon] ; Masahiro Tada [Japon] ; Yuko Sugioka [Japon] ; Kenji Mamoto [Japon] ; Shigeyuki Wakitani [Japon] ; Tatsuya Koike [Japon] ; Hiroaki Nakamura [Japon]Levels of interleukin-1 beta can predict response to tocilizumab therapy in rheumatoid arthritis: the PETITE (predictors of effectiveness of tocilizumab therapy) study.
001B68 (2016) Mar Maldonado-Montoro [Espagne] ; Marisa Ca Adas-Garre [Espagne] ; Alfonso González-Utrilla [Espagne] ; José Cristian Plaza-Plaza [Chili] ; Miguel Ngel Calleja-Hernández [Espagne]Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.
001C67 (2016) Mitsuhiro Akiyama [Japon] ; Yuko Kaneko [Japon] ; Kunihiro Yamaoka [Japon] ; Harumi Kondo [Japon] ; Tsutomu Takeuchi [Japon]Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
001F02 (2015) Takahiko Sugihara [Japon] ; Tatsuro Ishizaki [Japon] ; Tadashi Hosoya [Japon] ; Shoko Iga [Japon] ; Waka Yokoyama [Japon] ; Fumio Hirano [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE).
001F22 (2015) Ziga Rotar [Slovénie] ; Alojzija Ho Evar [Slovénie] ; Anamarija Rebolj Kodre [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]Retention of the second-line biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis failing one tumor necrosis factor alpha inhibitor: data from the BioRx.si registry.
002003 (2015) Toshihisa Kojima [Japon] ; Yuichiro Yabe [Japon] ; Atsushi Kaneko [Japon] ; Nobunori Takahashi [Japon] ; Koji Funahashi [Japon] ; Daizo Kato [Japon] ; Masahiro Hanabayashi [Japon] ; Shuji Asai [Japon] ; Shinya Hirabara [Japon] ; Nobuyuki Asai [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Masayo Kojima [Japon] ; Naoki Ishiguro [Japon]Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
002085 (2015) Vasco C. Romão [Portugal] ; Maria José Santos [Portugal] ; Joaquim Polido-Pereira [Portugal] ; Cátia Duarte [Portugal] ; Patrícia Nero [Portugal] ; Cláudia Miguel [Portugal] ; José Ant Nio Costa [Portugal] ; Miguel Bernardes [Portugal] ; Fernando M. Pimentel-Santos [Portugal] ; Filipe Barcelos [Portugal] ; Lúcia Costa [Portugal] ; José Ant Nio Melo Gomes [Portugal] ; José Alberto Pereira Da Silva [Portugal] ; Jaime Cunha Branco [Portugal] ; José Canas Da Silva [Portugal] ; José Ant Nio Pereira Da Silva [Portugal] ; João Eurico Fonseca [Portugal] ; Helena Canhão [Portugal]Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt.
002713 (2013) Meliha Crnkic Kapetanovic ; Tore Saxne ; Göran Jönsson ; Lennart Truedsson ; Pierre GeborekRituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
004348 (????) Shin-Ya Kawashiri [Japon] ; Ayako Nishino [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Yukitaka Ueki [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Munetoshi Nakashima [Japon] ; Akitomo Okada [Japon] ; Kiyoshi Migita [Japon] ; Akinari Mizokami [Japon] ; Naoki Matsuoka [Japon] ; Masanobu Mine [Japon] ; Soko Sakito [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Kiyoshi Aoyagi [Japon] ; Katsumi Eguchi [Japon] ; Atsushi Kawakami [Japon]Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
004407 (????) Laure Gossec [France] ; Ghislaine Steinberg [France] ; Stephanie Rouanet [France] ; Bernard Combe [France]Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study.
004452 (????) S. Kawashiri [Japon] ; Y. Ueki ; K. Migita ; H. Nakamura ; K. Aoyagi ; A. KawakamiBaseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Modèles logistiques" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Modèles logistiques" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Modèles logistiques
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021